Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) in Bihar, India. [electronic resource]
Producer: 20140908Description: e2536 p. digitalISSN:- 1935-2735
- Administration, Intravenous
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Amphotericin B -- administration & dosage
- Antiprotozoal Agents -- administration & dosage
- Child
- Child, Preschool
- Cohort Studies
- Female
- Humans
- India -- epidemiology
- Infant
- Leishmaniasis, Visceral -- drug therapy
- Male
- Middle Aged
- Recurrence
- Retrospective Studies
- Risk Factors
- Young Adult
No physical items for this record
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.